Sitagliptin
Sitagliptin is a pharmaceutical drug with 294 clinical trials. Currently 11 active trials ongoing. Historical success rate of 89.8%.
Success Metrics
Based on 221 completed trials
Phase Distribution
Phase Distribution
29
Early Stage
44
Mid Stage
178
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.7%
221 of 255 finished
13.3%
34 ended early
11
trials recruiting
294
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sitagliptin With Pembro in RCC and Melanoma
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer
A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.
Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
Clinical Trials (294)
Sitagliptin With Pembro in RCC and Melanoma
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer
A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.
Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.
Emulation of the EMPEROR-Reduced Trial Using Healthcare Claims Data
INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
Emulation of the EMPEROR-Preserved Trial Using Healthcare Claims Data
Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Anti-Diabetic Medications to Fight PD and LBD
Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
HbA1c Variability in Type II Diabetes
Emulation of the SOUL Diabetes Trial in Healthcare Claims
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 294